Publications by authors named "Erich Williams"

Claim this Profile
T
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.
Eileen Y Hu, Priscilla Do, Swagata Goswami, Jessica Nunes, Chi-Ling Chiang, Erich Williams

Blood Adv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human serum albumin and chromatin condensation rescue ex vivo expanded γδ T cells from the effects of cryopreservation.
Rebecca E Burnham, Donald Tope, Gianna Branella, Erich Williams, Christopher B Doering

Cryobiology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Donor Variability for γδ T Cell Expansion and Development of an Allogeneic γδ T Cell Immunotherapy.
Rebecca E Burnham, Jaquelyn T Zoine, Jamie Y Story, Swetha N Garimalla, Greg Gibson, Erich Williams

Front Med (Lausanne)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.
Zachary A Hing, Rose Mantel, Kyle A Beckwith, Daphne Guinn, Erich Williams, Katie Williams

Blood· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.
Dalia El-Gamal, Katie Williams, Taylor D LaFollette, Matthew Cannon, James S Blachly, Erich Williams

Blood· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis